The two tests that will help to predict spread of Covid-19

One detects past infection, the other finds current viral load – but there’s a shortage of staff trained to carry them outCoronavirus – latest updatesSee all our coronavirus coverageOnly by implementing carefully controlled programmes that use two very differentCovid-19 test kits will it be possible to predict how the disease will affect the country, researchers have revealed.Scientists emphasised the need to understand, as quickly as possible, where and when new cases of infection were appearing. At the same time, it was vital to pinpoint individuals who had already been infected, possibly without realising it, so that scientists could understand the disease ’s behaviour over the coming months. Two different tests would be able to achieve these separate goals.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Vaccines and immunisation Infectious diseases Medical research Science Society Health Microbiology Source Type: news

Related Links:

Conclusion: The T-cell epitope-based peptide vaccine was designed for COVID-19 using the envelope protein as an immunogenic target. Nevertheless, the proposed vaccine rapidly needs to be validated clinically in order to ensure its safety and immunogenic profile to help stop this epidemic before it leads to devastating global outbreaks. PMID: 32461973 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
Ken Terry Paul Grundy By PAUL GRUNDY, MD and KEN TERRY Date: June 20, 2022. The Smithsonian National Museum of Natural History has reported its biggest number of visitors in more than 2 ½ years. There’s a string of new Broadway musicals that are well-attended every night. It’s safe to shop in malls, eat out in restaurants and go to movie theaters again. Of course, this has all been made possible by an effective vaccine against COVID-19 that was widely administered in the fall of 2021. Vaccinated citizens of the world are now confident that it’s safe to go out in public, albeit with a...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Medical Practice Primary Care Ken Terry Paul Grundy Source Type: blogs
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
CONCLUSIONS: This new disease is pushing the scientific community to develop swiftly a safe and effective vaccine. Notwithstanding the limitations of our analysis, given by the absence of available results, we try to provide a comprehensive view of the ongoing clinical trials in humans. Our analysis reveals a worldwide effort of both scientists and enterprises to achieve one of the most challenging goals of our century. PMID: 32456404 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
Conclusions: The outbreak of the epidemic could promote coronavirus research, meanwhile, coronavirus research contributes to overcoming the epidemic. Attention should be drawn to the latest popular research, including “Spike protein,” “Receptor binding domain,” and “Vaccine.” Therefore, more and more efforts will be put into mechanism research and vaccine research and development, which can be helpful to deal with the epidemic.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
ammad Munir In the last 5 years, frequent outbreaks of infectious bronchitis virus (IBV) are observed in both broiler and layer chicken flocks in the Kingdom of Saudi Arabia (KSA) in spite of extensive usage of vaccines. The IBV is a widespread avian coronavirus affecting both vaccinated and unvaccinated chicken flocks and is attributed to significant economic losses, around the globe. In the present study, 58 (n = 58) samples were collected from four different commercial poultry flocks from 8 KSA districts during 2019. A total of nine positive isolates (9/58; 15.5%), based on real-time reverse transcriptase PCR target...
Source: Genes - Category: Genetics & Stem Cells Authors: Tags: Article Source Type: research
State Department-backed Armenian project to promote democracy instead features false informationCoronavirus – latest updatesSee all our coronavirus coverageThe US government is funding a website inArmenia which is spreading disinformation about the coronavirus pandemic, including warnings that Armenians ought to “refuse” future vaccine programmes.The website, Medmedia.am, was launched with the help of a US State Department grant meant to promote democracy, but instead has been used to promote false information about Covid-19, according toan investigation bythe Britishnews website openDemocracy.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Armenia World news US news Coronavirus outbreak Science Vaccines and immunisation Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
World ’s largest vaccine maker in talks with governments over manufacturing expansionCoronavirus – latest updatesSee all our coronavirus coverageGlaxoSmithKline plans to produce 1bn doses of vaccine efficacy boosters, or adjuvants, next year for use in Covid-19 treatment.The world ’s largest vaccine maker said it was in talks with governments to back a manufacturing expansion that would help to scale up production of future vaccines for Covid-19.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: GlaxoSmithKline Business Pharmaceuticals industry Vaccines and immunisation Immunology Health Biochemistry and molecular biology Medical research Science Society Coronavirus outbreak Infectious diseases World news Source Type: news
In one cruise-ship coronavirus outbreak, more than 80% of people who tested positive for COVID-19 did not show any symptoms of the disease, according to a new paper published in the journal Thorax. The research shows just how prevalent asymptomatic transmission of COVID-19 may be—a reality that both suggests official case counts are drastic underestimates, and emphasizes the importance of practicing social distancing even if you feel healthy. Researchers have known for months that asymptomatic transmission of COVID-19 is possible and common, but without population-wide testing, it’s been difficult to estimate h...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
More News: Coronavirus | COVID-19 | Infectious Diseases | Microbiology | Outbreaks | Research | Science | Vaccines